Concurrent Investment Advisors »

SPDR S&P Pharmaceuticals shares owned by Concurrent Investment Advisors

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Concurrent Investment Advisors from 13F filings

Historical chart of Concurrent Investment Advisors investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Concurrent Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Concurrent Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $337k 8.1k 41.62

More positions owned by Concurrent Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Total Stk Mkt (VTI)
First Tr Exchange-traded Dorsey Wrt 5 Etf (FV)
Amazon (AMZN)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr Technology (XLK)

View all positions for Concurrent Investment Advisors

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
Wells Fargo & Company
Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
First Citizens Bank & Trust
Bnp Paribas Arbitrage, Snc
Envestnet Portfolio Solutions
Wharton Business Group
UBS Group
MAI Wealth Advisors
Kingsview Wealth Management
Pnc Financial Services
Royal Bank of Canada
Citadel Advisors
AE Wealth Management

View all funds holding SPDR S&P Pharmaceuticals